News: SAiGENCI
SAiGENCI researchers given a funding boost
Researchers from the South Australian immunoGENomics Cancer Institute (SAiGENCI), based at the University of Adelaide, have been awarded funding to further their work in prostate and pancreatic cancers.
[Read more about SAiGENCI researchers given a funding boost]
Fellowship for fundamental epigenetic research
A University of Adelaide researcher investigating the essential processes of cells with the aim of opening up new opportunities for cancer treatment has received a national award.
[Read more about Fellowship for fundamental epigenetic research]
Epigenetic leader becomes University’s first Viertel Fellow
University of Adelaide molecular epigenetic expert Dr Luke Isbel has been awarded a 2024 Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship.
[Read more about Epigenetic leader becomes University’s first Viertel Fellow]
“I’m still alive because of it”: Cancer survivor’s research request
An Adelaide mother who was diagnosed with breast cancer at the age of 37 has urged people to dig deep to support cancer research, saying she wouldn’t be here today if not for science and her young daughter.
[Read more about “I’m still alive because of it”: Cancer survivor’s research request]
Cancer researcher’s leading new role at SAiGENCI
A world-leading researcher is bringing their cutting-edge cancer expertise and search for better treatments to South Australia.
[Read more about Cancer researcher’s leading new role at SAiGENCI]
SAiGENCI recruit recognised with prestigious award
Internationally recognised cancer expert, Professor Brendan Jenkins, has received the International Cytokine and Interferon Society (ICIS) 2023 Distinguished Service Award. He will be presented with the award at the annual ICIS conference in Athens, Greece, in October this year.
[Read more about SAiGENCI recruit recognised with prestigious award]
ENZAMET shows promise as prostate cancer treatment
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
[Read more about ENZAMET shows promise as prostate cancer treatment]
Top talent to boost cancer research
The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South Australian Immunogenomics Cancer Institute (SAiGENCI).
Placenta research puts spotlight on early weeks of human pregnancy
A University of Adelaide-led research project will deliver important new knowledge in the first weeks of human development to help reduce infertility and pregnancy complications.
[Read more about Placenta research puts spotlight on early weeks of human pregnancy]
Project investigates new approach to combat prostate cancer
A research team led by the University of Adelaide will investigate how prostate cancer cells survive and reappear after drug treatment.
[Read more about Project investigates new approach to combat prostate cancer ]
